Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could cord blood cells tame tough lupus?

NCT ID NCT07274059

Recruiting now Disease control Sponsor: Chengdu Ucello Biotechnology Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new treatment made from donated umbilical cord blood cells, designed to target and calm the overactive immune system in adults with severe lupus that hasn't responded to standard therapies. About 48 participants will receive the therapy to see if it is safe and can help control the disease. The goal is to reduce lupus activity and possibly allow patients to stop other medications, though long-term management may still be needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLE - SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The General Hospital of Western Theater Command

    NOT_YET_RECRUITING

    Chengdu, Sichuan, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yancheng Third People's Hospital

    RECRUITING

    Yancheng, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.